Dosage & Administration Drug label Prior authorization Financial assistance

Descovy

(emtricitabine / tenofovir alafenamide)

emtricitabine 120 MG / tenofovir alafenamide 15 MG Oral Tablet [Descovy]emtricitabine 200 MG / tenofovir alafenamide 25 MG Oral Tablet [Descovy]

BLACK BOX WARNING

Dosage & administration

* Testing: Prior to or when initiating DESCOVY, test for hepatitis B virus infection. Prior to or when initiating DESCOVY, and during use on a clinically appropriate schedule, assess serum creatinine, estimated creatinine clearance, urine glucose, and urine protein in all individuals. In individuals with chronic kidney disease, also assess serum phosphorus.
* HIV-1 Screening: Screen all individuals for HIV-1 infection immediately prior to initiating DESCOVY for HIV-1 PrEP and at least once every 3 months while taking DESCOVY, and upon diagnosis of any other sexually transmitted infections (STIs).
* Recommended dosage:
* Treatment of HIV-1 Infection:
* Adult and pediatric patients weighing at least 35 kg: One 200 mg/25 mg tablet once daily with or without food.
* Pediatric patients not receiving a protease inhibitor administered with ritonavir or cobicistat, and weighing:
* at least 25 to less than 35 kg: One 200 mg/25 mg tablet once daily with or without food.
* at least 14 to less than 25 kg: One 120 mg/15 mg tablet once daily with or without food.

* HIV-1 PrEP: One 200 mg/ 25 mg tablet once daily with or without food in individuals with body weight at least 35 kg.

* Renal impairment: DESCOVY is not recommended in individuals with estimated creatinine clearance of 15 to below 30 mL per minute, or below 15 mL per minute who are not receiving chronic hemodialysis.

drug label

Descovy prescribing information

Have more Descovy questions?

Submit MSL Request

Learn More

Need to report a Descovy issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Descovy Prior authorization resources

Complete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

Coverage Authorization Appeals

Prior Authorization Checklist

Learn More

Benefits investigation

Gilead Advancing Access Enrollment Form

Gilead Advancing Access Enrollment Form - Online

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Descovy Financial assistance options

Co-pay savings program

commercial only

Gilead Advancing Access Enrollment Form

Gilead Advancing Access Enrollment Form - Online

Enroll in Patient Savings Program

Activate Co-Pay Card (if already have one)

Replace Co-Pay Card (if lost one)

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Gilead Advancing Access Enrollment Form

Gilead Advancing Access Enrollment Form - Online

Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Descovy Patient education